Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 40 out of 100. Biomarkers

Topic: Risk, prevention and care in population studies

Abstract Identifying early markers of cognitive decline in cognitively normal older adults is critical for dementia prevention. Sensorimotor measures such as gait speed, grip strength, and reaction time may serve as accessible, sensitive indicators of current and future cognitive impairment. This study examined associations between baseline sensorimotor function and cognitive performance and decline, assessed by the Preclinical Alzheimer Cognitive Composite (PACC), in cognitively normal older adults. In this prospective cohort study, 246 cognitively normal older adults from the DRIVES Project completed baseline assessments of grip strength, gait speed, simple reaction time, and PACC scores. Linear mixed-effects models adjusted for demographic, genetic, and neighborhood depravity level. Cross-sectional analyses examined associations between sensorimotor measures and cerebrospinal fluid (CSF) biomarkers of amyloid and tau pathology, and plasma neurofilament light chain (NfL), where available. Participants (mean age: 74.9 ± 5.17 years; 48.8% female) followed on average for 4 years had a mean baseline PACC score of 1.06 ± 0.50. Cross-sectionally, slower gait speed was associated with higher CSF tau/Aβ42 ratio (p = 0.027), CSF tTau/Aβ42 ratio (p = 0.009), and plasma NfL (p = 0.024). Slower reaction time predicted lower baseline PACC scores (p = 0.028). Longitudinally, low grip strength (p = 0.002) and slow gait speed (p < 0.001) predicted lower cognitive performance, with slow gait speed predicting faster decline (p = 0.015). Simple sensory-motor function measures are associated with current and future cognitive performance, supporting their role in early identification of older adults at risk for cognitive decline.

Key findings

Why it matters

In cognitively normal older adults, slower gait speed was linked to higher CSF tau/Aβ42 and tTau/Aβ42 ratios and plasma NfL, and slower reaction time predicted lower baseline PACC scores. These simple sensorimotor measures may help identify people at risk of cognitive decline, but the study does not test any treatment or prevention.

Study details

How this study scored 40/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 40 of 100.40 of 100 points earned60 not earned

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Innovation in Aging)
Journal's citation record 0 / 4 Innovation in Aging: journal h-index 48 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Ganesh Muneshwar Babulal: h-index 31 (OpenAlex, whole career)
Institution's track record 2 / 3 Washington University in St. Louis: institution h-index 1,962 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 40 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Bekena, S., Singh, R. K., Zhu, Y., Carr, D., & Babulal, G. M. (2025). Sensorimotor measures predict longitudinal cognitive decline and correlate with CSF and plasma biomarkers. Innovation in Aging. https://doi.org/10.1093/geroni/igaf122.4258

Vancouver

Bekena S, Singh RK, Zhu Y, Carr D, Babulal GM. Sensorimotor measures predict longitudinal cognitive decline and correlate with CSF and plasma biomarkers. Innovation in Aging. 2025. doi:10.1093/geroni/igaf122.4258.

BibTeX

@article{bekena2025-e50209fd,
  author  = {Bekena, Semere and Singh, Ramkrishna Kumar and Zhu, Yu and Carr, David and Babulal, Ganesh Muneshwar},
  title   = {{Sensorimotor measures predict longitudinal cognitive decline and correlate with CSF and plasma biomarkers}},
  journal = {Innovation in Aging},
  year    = {2025},
  doi     = {10.1093/geroni/igaf122.4258},
  url     = {https://doi.org/10.1093/geroni/igaf122.4258}
}

Related studies in Biomarkers

Similar studies

More on Biomarkers

See all studies in Biomarkers →